For Regeneron, we transformed document-heavy workflows across four patient support programs spanning Oncology, Rare Disease, and Ophthalmology. The Document Triaging solution automated the intake of enrollment forms and clinical documents, including prescriptions, insurance cards, and updated program information directly from healthcare providers. By digitizing and validating this critical information, the system initiated benefit verification workflows seamlessly & other subsequent patient onboarding stages, reducing delays, errors, and manual effort while ensuring patients gained faster access to therapy.
Business Objectives
Each year, between November and March, Regeneron handles re-verification for over 300 patients to confirm their benefits for the upcoming year. This process was time-sensitive and involved multiple steps, making it both tedious and resource-intensive for the Patient Support Team. Timely execution was critical to ensure patients remained enrolled in the program without any service disruption.
Our Solution
Our team implemented a solution automating the following tasks to give a seamless experience to the Patient Support Team
- Fax blast to all HCPs involved in the Annual Re-verification based on their patients program timeline
- Automated Intake of Date of Services for upcoming year with the updated Insurance information
- Initiation of Electronic benefit verification workflow capturing Coverage Benefit information & program assignment based on outcome
- Assistance Program eligibility calculation based on the income information of the patient
Business Outcomes
- Intake from 200 plus HCPs is automated through Gen AI intervention reducing the processing time by 75%
- Automated Workflows & program Assignment eliminated manual interventions & reduced billing errors downstream by 15%
- Patient access to therapy has been increased by 3X resulting in increase in patient satisfaction
- By automating routine tasks, staff can focus on more critical activities, improving overall operational efficiency by 40%